NASDAQ:UAVS 21 July 2025

March 26, 2026, 8:50 AM EDT. Rockwell Medical (RMTI) reported a fourth-quarter loss of 1 cent per share, better than the expected 4-cent loss but missed revenue estimates with $18.35 million, down from $24.67 million a year earlier. The company, which produces kidney disease and anemia treatment products, has missed consensus earnings per share (EPS) estimates for four consecutive quarters. Despite recent market outperformance, with shares up 24.8% this year against the S&P 500's 3.7% decline, Rockwell Medical holds a Zacks Rank #3 (Hold) indicating expected in-line market performance. The current quarter consensus EPS estimate sits at negative 1 cent on $18.7 million revenue, signaling cautious investor sentiment amid mixed earnings outlooks.